CVE-2026-94033 SourceCodester CVE debrief

Who should care

Defenders responsible for the Drug Recommendation System 1.0 should assess exposure and prioritize verification and mitigation. This includes operators, platform administrators, vulnerability management teams, and security teams who need to verify potential exposure to cross-site scripting (XSS) attacks, assess the risk of remote exploitation, and prioritize patching or mitigating the vulnerability.

Why it matters

Defenders should care about CVE-2026-94033 because it allows for cross-site scripting (XSS) in the User Management component of Drug Recommendation System 1.0, which can be exploited remotely. The vulnerability requires verification of presence in systems, and defenders should prioritize patching or mitigation.

• Verify potential exposure to cross-site scripting (XSS) attacks
• Assess the risk of remote exploitation
• Prioritize patching or mitigating the vulnerability
• Monitor for potential exploitation attempts

Technical summary

The vulnerability affects the /drug_recommender/Admin/add_user file in the User Management component of Drug Recommendation System 1.0. It allows for cross-site scripting (XSS) when manipulating the txtname, txtemail, or txtpassword arguments. The attack can be launched remotely. Defenders should prioritize verifying the presence of this vulnerability in their systems and applying patches or mitigations as available. The CVE record and NVD entry provide details on the vulnerability, including its description, CVSS score, and affected components.

Defensive priority

Defenders should prioritize verifying the presence of this vulnerability in their systems and applying patches or mitigations as available.

Recommended defensive actions

• Verify the presence of this vulnerability in your systems
• Apply patches or mitigations as available
• Monitor for potential exploitation attempts
• Review compensating controls for exposed systems while remediation is scheduled and verified
• Check relevant monitoring, detection, and logs for exposed assets that need extra review
• Track exceptions, retest remediated assets, and close the item only after evidence is documented
• Confirm whether affected product deployments exist in managed environments and assign an owner for follow-up

Evidence notes

The CVE record and NVD entry provide details on the vulnerability, including its description, CVSS score, and affected components. However, the corpus does not establish versions, exploitation, impact, or remediation, which require verification from the supplied official sources.

Sources and references

Methodology and review provenance

AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.